Searle Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Searle Co Ltd with three other
companies in this sector in Pakistan:
Sanofi Aventis Pakistan Ltd
sales of 12.96 billion Pakistan Rupees [US$91.50 million]
of which 84%
Highnoon Laboratories Limited
(7.50 billion Pakistan Rupees [US$52.97 million]
Glaxosmithkline Consumer Healthcare Pakistan Ltd
(14.88 billion Pakistan Rupees [US$105.02 million]
During the year ended June of 2018, sales at
Searle Co Ltd were 16.40 billion Pakistan Rupees (US$115.75 million).
increase of 23.2%
versus 2017, when the company's sales were 13.31 billion Pakistan Rupees.
This was the fifth consecutive year of sales increases at Searle Co Ltd
(and since 2013, sales have increased a total of 173%).
Sales of Consumer saw an increase
that was more than double the company's growth rate: sales were up
55.3% in 2018, from
1.73 billion Pakistan Rupees to 2.68 billion Pakistan Rupees.